Open access
Open access
Powered by Google Translator Translator

Emergency Medicine

Review | Management of cardiogenic shock after acute coronary syndromes

18 Apr, 2023 | 13:27h | UTC

Management of cardiogenic shock after acute coronary syndromes – BJA Education

 


Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU

17 Apr, 2023 | 13:19h | UTC

Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations – Critical Care Medicine (free for a limited period)

Executive Summary: Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations – Critical Care Medicine (free for a limited period)

 


National clinical guideline for stroke for the UK and Ireland

17 Apr, 2023 | 13:15h | UTC

National clinical guideline for stroke for the UK and Ireland – Stroke Working Party (Full PDF here)

 


SR | Oral direct thrombin inhibitors vs. conventional anticoagulants for the treatment of pulmonary embolism

17 Apr, 2023 | 13:02h | UTC

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism – Cochrane Library

Summary: Are direct oral anticoagulants (a type of ‘blood thinner’) better than traditional anticoagulants for treating a pulmonary embolism (a blood clot in the lung)? – Cochrane Library

 


ESO expedited recommendation on tenecteplase for acute ischemic stroke

10 Apr, 2023 | 13:44h | UTC

European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke – European Stroke Journal

Related:

RCT | Tenecteplase noninferior to alteplase in acute ischemic cerebrovascular events

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials – Frontiers in Neurology

RCT: A single immediate dose of intravenous tenecteplase is noninferior to alteplase for the treatment of patients with acute ischemic stroke.

RCT: Tenecteplase vs. alteplase for the management of acute ischemic stroke.

Randomized Controlled Trial: Tenecteplase vs Alteplase before Thrombectomy for Ischemic Stroke

 


M-A | High-flow nasal cannula vs. noninvasive positive pressure ventilation in acute hypoxic respiratory failure

10 Apr, 2023 | 13:37h | UTC

High-Flow Nasal Cannula Compared With Noninvasive Positive Pressure Ventilation in Acute Hypoxic Respiratory Failure: A Systematic Review and Meta-Analysis – Critical Care Explorations

 


RCT | Routine invasive approach fails to benefit frail older adults with non–ST-segment elevation acute myocardial infarction

6 Apr, 2023 | 13:23h | UTC

Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentary: Routine invasive strategy not associated with improved outcomes in older adults with frailty and non-ST segment elevation acute myocardial infarction – Physician’s Weekly

 

Commentary on Twitter

 


Cohort Study | Maternal cardiac arrest: occurrence, survival, and influencing factors

6 Apr, 2023 | 12:59h | UTC

Cardiac Arrest During Delivery Hospitalization: A Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries:

Cardiac Arrest During Delivery Hospitalization – American College of Cardiology

Cardiac Arrest During Childbirth Is Rare, But Some Women Face Higher Risks – HealthDay

 

Commentary on Twitter

https://twitter.com/AnnalsofIM/status/1636095275545632768

 


Cohort Study | Multimodal prediction of favorable outcome after cardiac arrest

6 Apr, 2023 | 13:01h | UTC

Multimodal Prediction of Favorable Outcome After Cardiac Arrest: A Cohort Study – Critical Care Medicine

 


ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

5 Apr, 2023 | 13:45h | UTC

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia – Intensive Care Medicine

 

Commentary on Twitter

 


Review | Diagnosis and treatment of acute myocarditis

5 Apr, 2023 | 13:40h | UTC

Diagnosis and Treatment of Acute Myocarditis: A Review – JAMA (free for a limited period)

 


RCT | Endovascular treatment vs. no treatment after 6-24h in ischemic stroke patients with collateral flow on CT angiography

5 Apr, 2023 | 13:38h | UTC

Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)

 


RCT | Comparable results in endovascular therapy using general anesthesia vs. procedural sedation for stroke treatment

4 Apr, 2023 | 13:45h | UTC

Outcomes After Endovascular Therapy With Procedural Sedation vs General Anesthesia in Patients With Acute Ischemic Stroke: The AMETIS Randomized Clinical Trial – JAMA Neurology (free for a limited period)

See also: Visual Abstract

Related: M-A | General Anesthesia vs. to Non-GA in endovascular thrombectomy for ischemic stroke

 


RCT | Comparable efficacy of cefotaxime, ceftriaxone, and ciprofloxacin in treating spontaneous bacterial peritonitis

3 Apr, 2023 | 14:01h | UTC

Summary: This multicenter, prospective, open-label, randomized controlled trial compared the efficacy of cefotaxime, ceftriaxone, and ciprofloxacin as initial treatments for spontaneous bacterial peritonitis (SBP) in patients with cirrhosis and ascites. The study included 261 patients aged 16 to 75, with liver cirrhosis, ascites, and a polymorphonuclear cell count of >250/mm3. Researchers performed follow-up paracentesis at 48 hours to evaluate the assigned antibiotics, and assessed resolution rates at 120 and 168 hours of treatment.

The primary endpoint, resolution rates at 120 hours, showed no statistically significant difference between the groups: 67.8% for cefotaxime, 77.0% for ceftriaxone, and 73.6% for ciprofloxacin. One-month mortality rates were also similar. The study concluded that these antibiotics are equally effective as initial treatments for SBP, particularly for community-acquired infections, when administered based on response-guided therapy.

Article: Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP – American Journal of Gastroenterology (free for a limited period)

 


Review | Acute respiratory distress syndrome, mechanical ventilation, and inhalation injury in burn patients

3 Apr, 2023 | 13:38h | UTC

Acute Respiratory Distress Syndrome, Mechanical Ventilation, and Inhalation Injury in Burn Patients – Surgical Clinics

 


M-A | Incidence and prognostic role of pleural effusion in patients with pulmonary embolism

31 Mar, 2023 | 13:40h | UTC

Incidence and Prognostic Role of Pleural Effusion in Patients with Pulmonary Embolism: A Systematic Review and Meta-Analysis – Journal of Clinical Medicine

 


Review | Evaluation and management of hypernatremia in adults

30 Mar, 2023 | 14:20h | UTC

Evaluation and management of hypernatremia in adults: clinical perspectives – The Korean Journal of Internal Medicine

 


Update on the management of acute pancreatitis

30 Mar, 2023 | 14:10h | UTC

Update on the management of acute pancreatitis – Current Opinion in Critical Care

Related:

Intravenous fluid therapy in patients with severe acute pancreatitis admitted to the intensive care unit: a narrative review – Intensive Care Medicine

Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis – New England Journal of Medicine

Acute Pancreatitis: Diagnosis and Treatment – Drugs

Revised Clinical Practice Guidelines of the Korean Pancreatobiliary Association for Acute Pancreatitis – Gut and Liver

Guidelines for the management of patients with severe acute pancreatitis, 2021 – Anaesthesia Critical Care & Pain Medicine

Evidence-Based Disposition of Acute Pancreatitis – emDocs

2019 WSES guidelines for the management of severe acute pancreatitis – World Journal of Emergency Surgery

American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis

Pancreatitis – National Institute for Health and Care Excellence

The optimal timing and intervention to reduce mortality for necrotizing pancreatitis: a systematic review and network meta-analysis – World Journal of Emergency Surgery

Long-term follow-up of a RCT | Endoscopic versus surgical step-up approach for infected necrotizing pancreatitis.

RCT: Immediate drainage did not improve outcomes compared to postponed intervention in patients with infected necrotizing pancreatitis.

An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis – Gastroenterology

Research: Endoscopic or Surgical Step-up Approach for Infected Necrotising Pancreatitis

Evidence-Based Approach to the Surgical Management of Acute Pancreatitis – The Surgery Journal

 


Brief Review | Acute mesenteric ischemia

30 Mar, 2023 | 13:44h | UTC

Acute mesenteric ischaemia – British Journal of Surgery

 


M-A | Incidence of multiple organ failure in adult polytrauma patients

30 Mar, 2023 | 13:30h | UTC

Incidence of Multiple Organ Failure in Adult Polytrauma Patients: A Systematic Review and Meta-Analysis – Journal of Trauma and Acute Care Surgery

 


M-A | Aggressive IV hydration may increase mortality risk in severe acute pancreatitis

29 Mar, 2023 | 13:26h | UTC

Summary: This systematic review and meta-analysis investigated the outcomes of aggressive and non-aggressive intravenous hydration in patients with severe and non-severe acute pancreatitis (AP). The study included nine randomized controlled trials with a total of 953 participants.

The findings revealed that aggressive intravenous hydration significantly increased mortality risk in severe AP cases, and fluid-related complication risk in both severe and non-severe AP cases. However, the study has some limitations, as only one study with 249 participants was judged to have a low risk of bias in all domains, while the remaining eight studies had non-low risk of bias, raising concerns about the reliability of the findings.

Despite these concerns, the findings still suggest that more conservative intravenous fluid resuscitation protocols for AP may be preferable. Further research with more rigorous study designs is needed to provide robust evidence on the effectiveness of different intravenous hydration strategies in treating acute pancreatitis.

Article: Comparison of clinical outcomes between aggressive and non-aggressive intravenous hydration for acute pancreatitis: a systematic review and meta-analysis – Critical Care

 


Review | Supplemental oxygen and noninvasive ventilation

29 Mar, 2023 | 13:18h | UTC

Supplemental oxygen and noninvasive ventilation – European Respiratory Review

 


Practice Guidance | On-site treatment of avalanche victims

28 Mar, 2023 | 14:48h | UTC

On-site treatment of avalanche victims: Scoping review and 2023 recommendations of the international commission for mountain emergency medicine (ICAR MedCom) – Resuscitation

 


Acute heart failure: diagnostic–therapeutic pathways and preventive strategies — a real-world clinician’s guide

28 Mar, 2023 | 14:45h | UTC

Acute Heart Failure: Diagnostic–Therapeutic Pathways and Preventive Strategies—A Real-World Clinician’s Guide – Journal of Clinical Medicine

 


M-A | Examining shorter antibiotic treatment durations for community acquired pneumonia in adults

27 Mar, 2023 | 13:29h | UTC

Summary: The systematic review and duration-effect meta-analysis included nine randomized trials with a total of 2,399 patients, analyzing antibiotic treatment durations for community-acquired pneumonia (CAP) in adults. The primary outcome was clinical improvement on day 15, with secondary outcomes including all-cause mortality, serious adverse events, and clinical improvement on day 30.

The study found that shorter treatment durations (3–9 days) were likely to be non-inferior to the standard 10-day treatment, and no significant difference in all-cause mortality or serious adverse events was observed. The study suggests that a 3–5 day treatment duration likely offers the optimal balance between efficacy and treatment burden if patients are clinically stable. However, the results are limited by the small number of included studies, the overall moderate-to-high risk of bias, and the varying severity of CAP among patients in the studies. Therefore, further research focusing on the shorter duration range is required.

Article: Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis – BMJ Open

Related:

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians – Annals of Internal Medicine

Efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults: A systematic review and meta-analysis – Antimicrobial Agents and Chemotherapy

Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis – JAMA Pediatrics

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial – JAMA Pediatrics

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.